The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 341:1088-1089 September 30, 1999 Number 14
NextNext

Efficacy and Cost-Effectiveness of Psychotherapy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
(Clinical Practice.) Edited by David Spiegel. 199 pp. Washington, D.C., American Psychiatric Press, 1999. $28.50. ISBN 0-88048-769-0.

The past decade has seen a startling drop in the provision of insurance benefits for psychiatric care. Whereas the real value of employer-provided insurance for general medical treatment decreased 7.2 percent from 1988 to 1997, benefits for the treatment of psychiatric disorders fell by a dramatic 54 percent during that time. It is likely that a substantial part of this decline is accounted for by reluctance on the part of insurers, health maintenance organizations, and managed-care companies to provide benefits for psychotherapeutic treatment, which was once the mainstay of psychiatric care. Insurers and managed-care companies routinely refuse to authorize payment . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.